Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Verrica Pharmaceuticals (VRCA) Invested Capital (2021 - 2025)

Historic Invested Capital for Verrica Pharmaceuticals (VRCA) over the last 5 years, with Q3 2025 value amounting to $4.6 million.

  • Verrica Pharmaceuticals' Invested Capital fell 5051.87% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year decrease of 5051.87%. This contributed to the annual value of $21.1 million for FY2024, which is 6627.71% down from last year.
  • Per Verrica Pharmaceuticals' latest filing, its Invested Capital stood at $4.6 million for Q3 2025, which was down 5051.87% from $7.1 million recorded in Q2 2025.
  • Verrica Pharmaceuticals' 5-year Invested Capital high stood at $102.5 million for Q1 2021, and its period low was $4.6 million during Q3 2025.
  • For the 5-year period, Verrica Pharmaceuticals' Invested Capital averaged around $50.3 million, with its median value being $55.4 million (2023).
  • In the last 5 years, Verrica Pharmaceuticals' Invested Capital skyrocketed by 8921.93% in 2023 and then crashed by 8907.49% in 2024.
  • Verrica Pharmaceuticals' Invested Capital (Quarter) stood at $74.3 million in 2021, then crashed by 46.12% to $40.0 million in 2022, then skyrocketed by 56.46% to $62.6 million in 2023, then tumbled by 66.28% to $21.1 million in 2024, then plummeted by 78.32% to $4.6 million in 2025.
  • Its Invested Capital was $4.6 million in Q3 2025, compared to $7.1 million in Q2 2025 and $9.2 million in Q1 2025.